The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Self-citationImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,181
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
The dopamine hypothesis of reward: past and current status
Spanagel, R., & Weiss, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01447-2 · Cited by 973
Huang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
Self-citationWise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 875
Ohno-Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 845
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 812
Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 811
Kirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704767 · Cited by 788
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 775
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
Gerdeman, G. L., Ronesi, J., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
Self-citationModulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Glass, M., & Felder, C. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 635
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
Robbe, D., Kopf, M., Remaury, A., Bockaert, J., & Manzoni, O. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122149199 · Cited by 631
Porter, A. C., Sauer, J.-M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., Nomikos, G. G., Carter, P., Bymaster, F. P., Leese, A. B., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1020 · Cited by 615
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 594
Excitation of Ventral Tegmental Area Dopaminergic and Nondopaminergic Neurons by Orexins/Hypocretins
Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., & Brown, R. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00007.2003 · Cited by 583
Functional changes of the basal ganglia circuitry in Parkinson's disease
Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00067-2 · Cited by 582
Cannabis: pharmacology and toxicology in animals and humans
ADAMS, I. B., & MARTIN, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 570
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Di Marzo, V., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 541
Self-citationNeuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Involvement of CB1 cannabinoid receptors in emotional behaviour
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 507
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
Williams, C. M., & Kirkham, T. C. (1999) · Psychopharmacology · doi:10.1007/s002130050953 · Cited by 505
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Glass, M., Dragunow, M., & Faull, R. L. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00008-7 · Cited by 483
It could be habit forming: drugs of abuse and striatal synaptic plasticity
Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
Jamshidi, N., & Taylor, D. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704379 · Cited by 463
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia
Calabresi, P., Pisani, A., Mercuri, N. B., & Bernardi, G. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)81862-5 · Cited by 463
CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum
Gerdeman, G., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.468 · Cited by 433
A cannabinoid mechanism in relapse to cocaine seeking
De Vries, T. J., Shaham, Y., Homberg, J. R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L. J. M. J., & Schoffelmeer, A. N. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1151 · Cited by 432
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00008 · Cited by 432
Cohen, C., Perrault, G., Voltz, C., Steinberg, R., & Soubrié, P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00018 · Cited by 396
Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 393
Self-citationPharmacological and biochemical interactions between opioids and cannabinoids
Manzanares, J., Corchero, J., Romero, J., Fernández-Ruiz, J. J., Ramos, J. A., & Fuentes, J. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 392
Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00552-2 · Cited by 383
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
French, E. D., Dillon, K., & Wu, X. (1997) · NeuroReport · doi:10.1097/00001756-199702100-00014 · Cited by 374
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
Gessa, G., Melis, M., Muntoni, A., & Diana, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01442-8 · Cited by 370
Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., & Manzoni, O. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00109.2001 · Cited by 366
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 355
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02192.x · Cited by 354
Venance, L., Piomelli, D., Glowinski, J., & Glaume, C. (1995) · Nature · doi:10.1038/376590a0 · Cited by 352
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study
Sieradzan, K. A., Fox, S. H., Hill, M., Dick, J. P. R., Crossman, A. R., & Brotchie, J. M. (2001) · Neurology · doi:10.1212/wnl.57.11.2108 · Cited by 349
Tanda, G., Munzar, P., & Goldberg, S. R. (2000) · Nature Neuroscience · doi:10.1038/80577 · Cited by 345
Chen, J., Paredes, W., Li, J., Smith, D., Lowinson, J., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329
Gubellini, P., Picconi, B., Bari, M., Battista, N., Calabresi, P., Centonze, D., Bernardi, G., Finazzi-Agrò, A., & Maccarrone, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06900.2002 · Cited by 321
Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
Cadas, H., Gaillet, S., Beltramo, M., Venance, L., & Piomelli, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03934.1996 · Cited by 319
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
Maingret, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.47 · Cited by 313
Behavioral Effects of Cannabinoid Agents in Animals
Chaperon, F., & Thiebot, M.-H. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i3.20 · Cited by 311
di Marzo, V., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Self-citationDirect inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
Chemin, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299
Hermann, H., Marsicano, G., & Lutz, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00509-7 · Cited by 290
González, S., Grazia Cascio, M., Fernández-Ruiz, J., Fezza, F., Di Marzo, V., & Ramos, J. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03344-9 · Cited by 281
Self-citationSR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
Simiand, J., Keane, M., Keane, P. E., & Soubrié, P. (1998) · PubMed · Cited by 264
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors
Ghozland, S., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263
Marinelli, S., Di Marzo, V., Berretta, N., Matias, I., Maccarrone, M., Bernardi, G., & Mercuri, N. B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03136.2003 · Cited by 258
Self-citationCannabinoid Transmission and Reward-Related Events
Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 250
Huang, C., Lo, S., & Hsu, K. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0731e.x · Cited by 248
Di Marzo, V., De Petrocellis, L., Fezza, F., Ligresti, A., & Bisogno, T. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0349 · Cited by 242
Self-citationDeadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A., & Childers, S. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09495-9 · Cited by 241
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237
French, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236
Reversal of Dopamine D2Receptor Responses by an Anandamide Transport Inhibitor
Beltramo, M., de Fonseca, F. R., Navarro, M., Calignano, A., Gorriti, M. A., Grammatikopoulos, G., Sadile, A. G., Giuffrida, A., & Piomelli, D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03401.2000 · Cited by 232
Hao, S., Avraham, Y., Mechoulam, R., & Berry, E. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00059-5 · Cited by 229
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
Howlett, A. C., & Mukhopadhyay, S. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00187-0 · Cited by 229
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
Ujike, H., Takaki, M., Nakata, K., Tanaka, Y., Takeda, T., Kodama, M., Fujiwara, Y., Sakai, A., & Kuroda, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001029 · Cited by 228
Emrich, H. M., Leweke, F. M., & Schneider, U. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00426-1 · Cited by 226
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
Berrendero, F., & Maldonado, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 222
A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice
Valjent, E., & Maldonado, R. (2000) · Psychopharmacology · doi:10.1007/s002130050013 · Cited by 214
Activational role of cannabinoids on movement
Sañudo-Peña, M. C., Romero, J., Seale, G. E., Fernandez-Ruiz, J. J., & Walker, J. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00044-3 · Cited by 210
Cannabinoid Addiction: Behavioral Models and Neural Correlates
Maldonado, R., & Rodrı́guez de Fonseca, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205
Facilitation of brain stimulation reward byΔ 9-tetrahydrocannabinol
Gardner, E. L., Paredes, W., Smith, D., Donner, A., Milling, C., Cohen, D., & Morrison, D. (1988) · Psychopharmacology · doi:10.1007/bf02431546 · Cited by 204
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., & Fratta, W. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00052-9 · Cited by 202
Thaker, G. K., & Carpenter, W. T. (2001) · Nature Medicine · doi:10.1038/89040 · Cited by 200
De Vries, T. J., Homberg, J. R., Binnekade, R., Raasø, H., & Schoffelmeer, A. N. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1422-1 · Cited by 198
Hoffman, A. F., & Lupica, C. R. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.72 · Cited by 194
Hoffman, A. F., Oz, M., Caulder, T., & Lupica, C. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04815.2003 · Cited by 193
Mesolimbic dopaminergic decline after cannabinoid withdrawal
Diana, M., Melis, M., Muntoni, A. L., & Gessa, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10269 · Cited by 192
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
Hilairet, S., Bouaboula, M., Carrière, D., Le Fur, G., & Casellas, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212369200 · Cited by 190
Julian, M. D., Martin, A. B., Cuellar, B., Rodriguez De Fonseca, F., Navarro, M., Moratalla, R., & Garcia-Segura, L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00070-8 · Cited by 188
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats
Fattore, L., Cossu, G., Martellotta, C., & Fratta, W. (2001) · Psychopharmacology · doi:10.1007/s002130100734 · Cited by 187
Lastres‐Becker, I., Cebeira, M., de Ceballos, M. L., Zeng, B. ‐., Jenner, P., Ramos, J. A., & Fernández‐Ruiz, J. J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01812.x · Cited by 185
CB cannabinoid receptor signalling in Parkinson’s disease
BROTCHIE, J. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00011-5 · Cited by 179
The central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 178
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters
Arévalo, C., de Miguel, R., & Hernández-Tristán, R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00578-0 · Cited by 175
Cannabis induced dopamine release: an in-vivo SPECT study
Voruganti, L. N. P., Slomka, P., Zabel, P., Mattar, A., & Awad, A. G. (2001) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(01)00104-4 · Cited by 172
Denovan-Wright, E. M., & Robertson, H. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00157-3 · Cited by 169
Di Marzo, V., Berrendero, F., Bisogno, T., González, S., Cavaliere, P., Romero, J., Cebeira, M., Ramos, J. A., & Fernández‐Ruiz, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741627.x · Cited by 168
Self-citationMolecular targets in the treatment of anxiety
Kent, J. M., Mathew, S. J., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01672-4 · Cited by 167
Higgs, S., Williams, C. M., & Kirkham, T. C. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1263-3 · Cited by 165
Cannabinoids modulate potassium current in cultured hippocampal neurons.
Deadwyler, S. A., Hampson, R. E., Bennett, B. A., Edwards, T. A., Mu, J., Pacheco, M. A., Ward, S. J., & Childers, S. R. (1993) · PubMed · Cited by 164
Lichtman, A. H., Sheikh, S. M., Loh, H. H., & Martin, B. R. (2001) · PubMed · Cited by 156
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism
Maccarrone, M., Gubellini, P., Bari, M., Picconi, B., Battista, N., Centonze, D., Bernardi, G., Finazzi‐Agrò, A., & Calabresi, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01759.x · Cited by 143
Acute Neuronal Injury, Excitotoxicity, and the Endocannabinoid System
van der Stelt, M., Veldhuis, W. B., Maccarrone, M., Bär, P. R., Nicolay, K., Veldink, G. A., Marzo, V. D., & Vliegenthart, J. F. G. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:317 · Cited by 143
Lastres‐Becker, I., de Miguel, R., PETROCELLIS, L. D., Makriyannis, A., Marzo, V. D., & Fernández‐Ruíz, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01595.x · Cited by 142
Ton, J. M. N. C., Gerhardt, G. A., Friedemann, M., Etgen, A. M., Rose, G., Sharpless, N. S., & Gardner, E. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90749-4 · Cited by 141
Gorriti, M. Á., de Fonseca, F. R., Navarro, M., & Palomo, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00851-6 · Cited by 137
Harrold, J. A., Elliott, J. C., King, P., Widdowson, P. S., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03245-6 · Cited by 137
Study of cannabinoid dependence in animals
Maldonado, R. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00254-1 · Cited by 136
González, S. R., Fernández‐Ruíz, J., Sparpaglione, V., Parolaro, D., & Ramos, J. A. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00186-7 · Cited by 133
Maneuf, Y. P., Nash, J. E., Crossman, A. R., & Brotchie, J. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00326-3 · Cited by 132
Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
Szabó, B., Wallmichrath, I., Mathonia, P., & Pfreundtner, C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00036-1 · Cited by 130
Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in rats
Fattore, L., Spano, M. S., Cossu, G., Deiana, S., & Fratta, W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02607.x · Cited by 128
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
Al-Hayani, A., Wease, K. N., Ross, R. A., Pertwee, R. G., & Davies, S. N. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00145-9 · Cited by 128
Cadogan, A., Alexander, S. P. H., Boyd, E. A., & Kendall, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031131.x · Cited by 127
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
Marzo, V. D., Lastres‐Becker, I., Bisogno, T., PETROCELLIS, L. D., Milone, A., Davis, J. B., & Fernández‐Ruíz, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01012-3 · Cited by 127
Melis, M., Gessa, G. L., & Diana, M. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00119-6 · Cited by 125
Morphine-Dependent Rats: Blockade of Precipitated Abstinence by Tetrahydrocannabinol
Hine, B., Friedman, E., Torrelio, M., & Gershon, S. (1975) · Science · doi:10.1126/science.1167428 · Cited by 125
Mailleux, P., & Vanderhaeghen, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09807.x · Cited by 122
Szabó, B., Müller, T., & Koch, H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731084.x · Cited by 120
Fox, S. H., Kellett, M., Moore, A. P., Crossman, A. R., & Brotchie, J. M. (2002) · Movement Disorders · doi:10.1002/mds.1280 · Cited by 120
Vela, G., Ruiz-gayo, M., & Fuentes, J. A. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00032-2 · Cited by 118
Lamarque, S., Taghzouti, K., & Simon, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00039-9 · Cited by 116
Lastres‐Becker, I., Hansen, H. H., Berrendero, F., de Miguel, R., Pérez‐Rosado, A., Manzanares, J., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Synapse · doi:10.1002/syn.10054 · Cited by 116
Wu, X., & French, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00140-9 · Cited by 116
Leroy, S., Griffon, N., Bourdel, M., Olié, J., Poirier, M. F., & Krebs, M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10038 · Cited by 115
Romero, J., Berrendero, F., Pérez‐Rosado, A., Manzanares, J., Rojo, A., Fernández‐Ruíz, J., de Yébenes, J. G., & Ramos, J. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00618-9 · Cited by 112
Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice
Valverde, O., Maldonado, R. J., Valjent, E., Zimmer, A. M., & Zimmer, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09284.2000 · Cited by 111
Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse
Wallmichrath, I., & Szabó, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00109-4 · Cited by 110
The dopaminergic modulation of fear: Quinpirole impairs the recall of emotional memories in rats.
Nader, K., & LeDoux, J. E. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.1.152 · Cited by 109
Meschler, J. P., & Howlett, A. C. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00012-0 · Cited by 107
Anandamide: an endogenous activator of the vanilloid receptor
Smart, D., & Jerman, J. C. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01459-0 · Cited by 105
Yamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02655-5 · Cited by 104
Lastres‐Becker, I., Berrendero, F., Lucas, J. J., Martı́n-Aparicio, E., Yamamoto, A., Ramos, J. A., & Fernández‐Ruíz, J. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03403-5 · Cited by 103
Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens
Manzoni, O. J., & Bockaert, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00723-3 · Cited by 103
Leweke, F. M., Schneider, U., Thies, M., Münte, T. F., & Emrich, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050884 · Cited by 102
Romero, J., García‐García, L., Fernández‐Ruíz, J., Cebeira, M., & Ramos, J. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00023-p · Cited by 100
Malone, D. T., & TAYLOR, D. A. H. B. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702753 · Cited by 99
Viganò, D., Cascio, M. G., Rubino, T., Fezza, F., Vaccani, A., Marzo, V. D., & Parolaro, D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300117 · Cited by 99
Fan, F., Tao, Q., Abood, M. E., & Martin, B. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01113-7 · Cited by 97
Sa√±udo-Pe√±a, M. C., Force, M., Tsou, K., Miller, A. S., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<221::aid-syn12>3.0.co;2-4 · Cited by 93
Sagan, S., Venance, L., Torrens, Y., Cordier, J., Glowinski, J., & Giaume, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00480.x · Cited by 90
Dependence of mesolimbic dopamine transmission on Δ9-tetrahydrocannabinol
Tanda, G., Loddo, P., & Chiara, G. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00384-2 · Cited by 89
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease
Lastres‐Becker, I., Fezza, F., Cebeira, M., Bisogno, T., Ramos, J. A., Milone, A., Fernández‐Ruíz, J., & Marzo, V. D. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00017 · Cited by 89
Pistis, M., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02019.x · Cited by 88
Meschler, J. P., Howlett, A. C., & Madras, B. K. (2001) · Psychopharmacology · doi:10.1007/s002130100728 · Cited by 87
Maneuf, Y. P., Crossman, A. R., & Brotchie, J. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6645 · Cited by 83
Modulation of Neurotransmission by Cannabinoids in the Basal Ganglia
Glass, M., Brotchie, J. M., & Maneuf, Y. P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01390.x · Cited by 83
Role of the Subthalamic Nucleus in Cannabinoid Actions in the Substantia Nigra of the Rat
Sañudo-Peña, M. C., & Walker, J. M. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.3.1635 · Cited by 82
Δ 9 -Tetrahydrocannabinol: Aversive Effects in Rat at High Doses
Elsmore, T. F., & Fletcher, G. V. (1972) · Science · doi:10.1126/science.175.4024.911 · Cited by 80
Silverdale, M., McGuire, S., McInnes, A., Crossman, A. R., & Brotchie, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7649 · Cited by 80
Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats
Marı́n, S., Marco, E. M., Biscaia, M., Fernández, B., Rubio, M., Guaza, C., Schmidhammer, H., & Viveros, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01041-9 · Cited by 78
Segovia, G., Mora, F., Crossman, A. R., & Brotchie, J. M. (2002) · Movement Disorders · doi:10.1002/mds.10312 · Cited by 77
The role of Cannabinoids in neurodegenerative diseases
Glass, M. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00162-2 · Cited by 77
Sañudo-Peña, M. C., Patrick, S. L., Patrick, R. L., & Walker, J. M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12436-8 · Cited by 75
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9 · Cited by 73
Wiley, J. L., Huffman, J. W., Balster, R. L., & Martin, B. R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01193-5 · Cited by 70
Rubino, T., Viganò, D., Massi, P., Spinello, M., Zagato, E., Giagnoni, G., & Parolaro, D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00196-3 · Cited by 70
Nahas, G. G. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_79 · Cited by 68
Endocannabinoids New Targets for Drug Development
Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399365 · Cited by 68
Endocannabinoids and basal ganglia functionality
Fernández‐Ruíz, J., Lastres‐Becker, I., Cabranes, A., González, S. R., & Ramos, J. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0350 · Cited by 65
Cannabinoid Receptor‐Regulated Cyclic AMP Accumulation in the Rat Striatum
Bidaut‐Russell, M., & Hewlett, A. C. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06379.x · Cited by 64
Cannabinoid-induced Fos expression within A10 dopaminergic neurons
Patel, S., & Hillard, C. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03797-6 · Cited by 63
Rubino, T., Patrini, G., Parenti, M. D., Massi, P., & Parolaro, D. (1997) · Molecular Brain Research · doi:10.1016/s0006-8993(96)00941-9 · Cited by 63
Maneuf, Y. P., Crossman, A. R., & Brotchie, J. M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199604)22:4<382::aid-syn9>3.0.co;2-7 · Cited by 62
Anderson, J. J., Kask, A. M., & Chase, T. N. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00661-3 · Cited by 51
Sa√±udo-Pe√±a, M. C., & Walker, J. M. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199801)28:1<27::aid-syn4>3.0.co;2-e · Cited by 51
Recent advances in Huntingtonʼs disease: implications for experimental therapeutics
Feigin, A., & Zgaljardic, D. J. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00013 · Cited by 50
Rubino, T., Viganò, D., Costa, B., Colleoni, M., & Parolaro, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752478.x · Cited by 46
Page, K. J., Besret, L., Jain, M., Monaghan, E., Dunnett, S. B., & Everitt, B. J. (2000) · Experimental Brain Research · doi:10.1007/s002210050016 · Cited by 44
Precipitated and spontaneous withdrawal in rats tolerant to anandamide
Costa, B., Giagnoni, G., & Colleoni, M. (2000) · Psychopharmacology · doi:10.1007/s002139900360 · Cited by 44
Muschamp, J. W., & Siviy, S. M. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00910-3 · Cited by 44
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404
del Arco, I., Navarro, M., Bilbao, A., Ferrer, B., Piomelli, D., & de Fonseca, F. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02483-4 · Cited by 43
Romero, J., Fernández‐Ruíz, J., Vela, G., Ruiz‐Gayo, M., Fuentes, J. A., & Ramos, J. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00036-2 · Cited by 38
Tsai, S., Wang, Y., & Hong, C. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1259 · Cited by 32
Conceptual problems of research on emotions.
Ie, F., & Lj, W. (1960) · PubMed · Cited by 32
Meschler, J. P., Clarkson, F. A., Mathews, P. J., Howlett, A. C., & Madras, B. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35375-3 · Cited by 21
Metabolic Fate of Endocannabinoids
van der Stelt, M., & Marzo, V. D. (2004) · Current Neuropharmacology · doi:10.2174/1570159043476864 · Cited by 12
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 783
Cannabinoid physiology and pharmacology: 30 years of progress
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608
Metadata
- Authors
- van der Stelt, M., & Di Marzo, V.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 480
- Issue
- 1-3
- Pages
- 133-150
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1979656019
- Cited by
- 291
- References
- 195
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.